Expert Guidance for Effective Management and Appropriate Monitoring of Patients With Pain

Listen as Amanda Zimmerman, PA-C, and Chin Hwa (Gina) Dahlem, PhD, FNP-C, answer audience questions that were submitted at the June 2023 webinar titled, “Safe and Smart: Teaching Patients About Safe Opioid Practices.” Their answers cover topics including how to conduct a pill count and cost concerns regarding naloxone. Presenters: Chin Hwa (Gina) Dahlem, PhD, FNP-C Clinical Associate Professor School of Nursing University of Michigan Nurse Practitioner Packard Health Ann Arbor, Michigan Amanda Zimmerman, PA-C Physician Assistant West Forsyth Pain Management Winston-Salem, North Carolina This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA. Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE. Link to full program: https://bit.ly/44wOqkc

In this episode, Michael Sprintz, DO, DFASAM, and Tia, a patient and advocate, talk about their experiences with opioid use disorder, pain, and the road to recovery. This podcast aims to differentiate opioid dependency from opioid use disorder, decrease the stigma of opioid misuse, and encourage those affected by it to seek treatment. The informative discussion includes first-hand perspectives of developing opioid dependency, a call to action for both healthcare professionals and patients to remember that addiction is a biological disorder and the importance of open communication to build a strong support system in the face of addiction. 

Listen as Vanila M. Singh, MD, MACM, and Theresa Mallick-Searle,MS, PMGT-BC, ANP-BC, provide thoughtful answers and clinical insights to audience questions that were submitted at a recent webinar about developing individualized pain treatment plans. Topics covered in this podcast include risk assessment, navigating the balance between “law enforcement” and “healthcare professional” when prescribing opioids, and prescription drug monitoring programs.Presenters:Vanila M. Singh, MD, MACMClinical Associate ProfessorStanford University School of MedicinePalo Alto, CaliforniaFMR Chief Medical OfficerUS Department of Health and Human ServicesChairpersonCongressionally Mandated Pain Task ForceTheresa Mallick-Searle, MS, PMGT-BC, ANP-BCAdult Nurse PractitionerDivision Pain MedicineStanford Health CareRedwood City, CaliforniaThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi 

Listen as Amanda Zimmerman, PA-C, answers the most pressing questions from the first live webinar of the 2022-2023 Opioid REMS Education Initiative, “What All Practitioners Should Know About Mechanisms and Assessment of Pain.”Presenter:Amanda Zimmerman, PA-CPhysician AssistantWest Forsyth Pain ManagementWinston-Salem, North CarolinaThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi 

Listen as Vanila Singh, MD, MACM, speaks with Maggie Buckley, a woman with Ehlers-Danlos syndrome and chronic pain, about her experience with pain therapies and different healthcare professionals over the years. They have an enlightening discussion about the challenges both patients and healthcare professionals face in optimizing pain management, with a poignant conversation about how stigma plays a role in pain medicine. They close by offering advice to fellow healthcare professionals and patients on how to approach pain management from both perspectives.Presenters:Vanila Singh, MD, MACMClinical Associate Professor Department of Anesthesiology, Peri-operative, and Pain MedicineStanford School of MedicinePalo Alto, CaliforniaChairperson, Former Chief Medical OfficerHHS Pain Management Pain Task ForceUS Department of Health and Human ServicesMaggie Buckley  This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi 

Listen as  Samantha Catanzano, PharmD, BCPP; Andrew Friedman, MD; and Mark Queralt, MD, answer the most pressing questions from 2 live webinars covering nonpharmacologic, nonopioid, and opioid pharmacologic options for pain management. These webinars are part of the 2022-2023 Opioid REMS Education Initiative and are titled, “Managing Pain: A Focus on Nonpharmacologic and Nonopioid Approaches” and “Managing Pain: A Focus on Opioid Analgesic Approaches.”Presenters:Samantha Catanzano, PharmD, BCPPClinical Assistant ProfessorDivision of Pharmacy PracticeThe University of Texas at Austin  College of PharmacyBoard-Certified Psychiatric PharmacistIntegrated Behavioral Health DepartmentAustin, TexasAndrew Friedman, MDSection Head, Physical Medicine and RehabilitationVirginia Mason Medical CenterClinical Assistant ProfessorUniversity of WashingtonSeattle, WashingtonMark Queralt, MDAssistant ProfessorDirector of the Musculoskeletal InstituteBack and Neck Pain Clinical DirectorUniversity of Texas Health AustinAustin, TexasThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi   

Listen as Stefan Kertesz, MD, MSc, and Kate M. Nicholson, JD, provide unique healthcare professional and patient perspectives on opioid tapering in the setting of chronic pain management. Their conversation includes commentary on the impact of the 2016 and 2022 CDC guidelines for prescribing opioids for pain, the importance of informed consent, and the ongoing research regarding risks and consequences of opioid tapers.Select links to resources related to the content of this podcast episode include:Assessing Reasons for Decreased Primary Care Access for Individuals on Prescribed Opioids: An Audit Study journals.lww.com/pain/Citation/2021/05000/Assessing_reasons_for_decreased_primary_care.11.aspxPatient-Centered Prescription Opioid Tapering in Community Outpatients With Chronic Pain ncbi.nlm.nih.gov/pmc/articles/PMC5876887Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy jamanetwork.com/journals/jamanetworkopen/fullarticle/2795159Stefan G. Kertesz, MD, MScProfessor of MedicineDepartment of MedicineDivision of Preventive MedicineUAB Heersink School of MedicineBirmingham, Alabama  Kate M. Nicholson, JD  This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi    

Listen as Amanda Zimmerman, PA-C, and Chin Hwa (Gina) Dahlem, PhD, FNP-C, answer audience questions that were submitted at the June 2023 webinar titled, “Safe and Smart: Teaching Patients About Safe Opioid Practices.” Their answers cover topics including how to conduct a pill count and cost concerns regarding naloxone.Presenters:Chin Hwa (Gina) Dahlem, PhD, FNP-CClinical Associate ProfessorSchool of NursingUniversity of MichiganNurse PractitionerPackard HealthAnn Arbor, MichiganAmanda Zimmerman, PA-CPhysician AssistantWest Forsyth Pain ManagementWinston-Salem, North CarolinaThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi 

Listen as Stefan Kertesz, MD, MSc, and Kate M. Nicholson, JD, provide unique healthcare professional and patient perspectives on opioid tapering in the setting of chronic pain management. Their conversation includes commentary on the impact of the 2016 and 2022 CDC guidelines for prescribing opioids for pain, the importance of informed consent, and the ongoing research regarding risks and consequences of opioid tapers.Select links to resources related to the content of this podcast episode include:• Assessing Reasons for Decreased Primary Care Access for Individuals on Prescribed Opioids: An Audit Studyjournals.lww.com/pain/Citation/2021/05000/Assessing_reasons_for_decreased_primary_care.11.aspx• Patient-Centered Prescription Opioid Tapering in Community Outpatients With Chronic Painncbi.nlm.nih.gov/pmc/articles/PMC5876887• Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapyjamanetwork.com/journals/jamanetworkopen/fullarticle/2795159Presenters:Stefan Kertesz, MD, MScProfessor of MedicineDepartment of MedicineDivision of Preventive MedicineUAB Heersink School of MedicineBirmingham, AlabamaKate M. Nicholson, JDThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

Listen as Vanila M. Singh, MD, MACM, and Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, provide thoughtful answers and clinical insights to audience questions that were submitted at a recent webinar about developing individualized pain treatment plans. Topics covered in this podcast include risk assessment, navigating the balance between “law enforcement” and “healthcare professional” when prescribing opioids, and prescription drug monitoring programs.Presenters:Vanila M. Singh, MD, MACMClinical Associate ProfessorStanford University School of MedicinePalo Alto, CaliforniaFMR Chief Medical OfficerUS Department of Health and Human ServicesChairpersonCongressionally Mandated Pain Task ForceTheresa Mallick-Searle, MS, PMGT-BC, ANP-BCAdult Nurse PractitionerDivision Pain MedicineStanford Health CareRedwood City, CaliforniaThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi  

Listen as Vanila Singh, MD, MACM, speaks with Maggie Buckley, a woman with Ehlers-Danlos syndrome and chronic pain, about her experience with pain therapies and different healthcare professionals over the years. They have an enlightening discussion about the challenges both patients and healthcare professionals face in optimizing pain management, with a poignant conversation about how stigma plays a role in pain medicine. They close by offering advice to fellow healthcare professionals and patients on how to approach pain management from both perspectives.Presenters:Vanila Singh, MD, MACMClinical Associate ProfessorDepartment of Anesthesiology, Peri-operative, and Pain MedicineStanford School of MedicinePalo Alto, CaliforniaChairperson, Former Chief Medical OfficerHHS Pain Management Pain Task ForceUS Department of Health and Human ServicesMaggie BuckleyThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi 

Listen as  Samantha Catanzano, PharmD, BCPP; Andrew Friedman, MD; and Mark Queralt, MD, answer the most pressing questions from 2 live webinars covering nonpharmacologic, nonopioid, and opioid pharmacologic options for pain management. These webinars are part of the 2022-2023 Opioid REMS Education Initiative and are titled, “Managing Pain: A Focus on Nonpharmacologic and Nonopioid Approaches” and “Managing Pain: A Focus on Opioid Analgesic Approaches.”Presenters:Samantha Catanzano, PharmD, BCPPClinical Assistant ProfessorDivision of Pharmacy PracticeThe University of Texas at AustinCollege of PharmacyBoard-Certified Psychiatric PharmacistIntegrated Behavioral Health DepartmentAustin, TexasAndrew Friedman, MDSection Head, Physical Medicine and RehabilitationVirginia Mason Medical CenterClinical Assistant ProfessorUniversity of WashingtonSeattle, WashingtonMark Queralt, MDAssistant ProfessorDirector of the Musculoskeletal InstituteBack and Neck Pain Clinical DirectorUniversity of Texas Health AustinAustin, TexasThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

Listen as Amanda Zimmerman, PA-C, answers the most pressing questions from the first live webinar of the 2022-2023 Opioid REMS Education Initiative, “What All Practitioners Should Know About Mechanisms and Assessment of Pain.”Presenter:Amanda Zimmerman, PA-CPhysician AssistantWest Forsyth Pain ManagementWinston-Salem, North CarolinaThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi 

Listen as Lisa Phipps, PharmD, PhD, provides an overview of the 2022-2023 Opioid REMS Education Initiative, “Patient-Centered Pain Management: An Expert’s Guide to Safe, Effective, and Appropriate Care for Patients With Pain.” This yearlong educational program will bring you complimentary live webinars, on-demand videos, podcasts, decision tools, and ClinicalThought blog posts—all developed with the help of pain and addiction specialists to provide the most up-to-date, clinically sound information on managing patients with pain and/or substance use disorder. In addition, webinars and webcasts will be available for CE/CME credits applicable to all healthcare professionals to further enhance your education and practice.Presenter:Lisa Phipps, PharmD, PhDThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

In this episode, Michael Weaver, MD, DFASAM, provides information on both nonpharmacologic and pharmacologic treatment options for patients with opioid use disorder. Listeners will gain an understanding of the available counseling programs and medications for opioid use disorder—methadone, buprenorphine, and naltrexone—including the patient scenarios for which each may be most appropriate. In addition, Dr Weaver emphasizes that substance use disorder is a chronic condition and that optimal treatment involves a multimodal approach.Presenter:  Michael Weaver, MD, DFASAMProfessorDepartment of Psychiatry and Behavioral SciencesMedical DirectorCenter for Neurobehavioral Research on AddictionMcGovern Medical SchoolUniversity of Texas Health Science Center at HoustonHouston, TexasThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

In this episode, Michael Weaver, MD, DFASAM, and Sung Cheol Kim, MSN, PMHNP-BC, have an interprofessional discussion of patient cases centered on managing opioid use disorder (OUD). The experts cover both pharmacologic and nonpharmacologic treatment options, including comparisons of the medications available for OUD. Throughout the discussion, listeners also will learn about addressing OUD with a patient in a professional, nonjudgmental manner; exit strategies for opioid analgesic treatment regimens after OUD is identified; and how to continually assess the level of care that a patient with OUD may need throughout treatment. Presenters:  Michael Weaver, MD, DFASAMProfessorDepartment of Psychiatry and Behavioral SciencesMedical DirectorCenter for Neurobehavioral Research on AddictionMcGovern Medical SchoolUniversity of Texas Health Science Center at HoustonHouston, TexasSung Cheol Kim, MSN, PMHNP-BCAdjunct FacultySchool of NursingVirginia Commonwealth UniversityPsychiatric Nurse PractitionerDepartment of PsychiatryVCU HealthRichmond, VirginiaThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

In this episode, Michael Weaver, MD, DFASAM, discusses the complexities of substance use disorder. He details the neurobiology of addiction, emphasizing that developing a substance use disorder is a brain disease, not a personal choice. Listen in as Dr Weaver provides information on risk factors and screening tools for substance use disorders, as well as helpful guidance on reducing stigma and effectively communicating with patients and caregivers.Presenter:  Michael Weaver, MD, DFASAMProfessorDepartment of Psychiatry and Behavioral SciencesMedical DirectorCenter for Neurobehavioral Research on AddictionMcGovern Medical SchoolUniversity of Texas Health Science Center at HoustonHouston, TexasThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

In this episode,Michael Weaver, MD, DFASAM, and Sung (Sunny) Cheol Kim, MSN, PMHNP-BC, have an interprofessional discussion of patient cases centered on substance use disorders. Each expert provides a real-world case example from their practice and weighs in on the importance of educating all healthcare professionals on screening and management practices for use disorders. Listen as they discuss the complexities of addiction and patient care. One case focuses on a patient who is already receiving opioid therapy but has begun exhibiting signs of an opioid use disorder, and the other focuses on a patient who wants to try an opioid prescription but has several “red flags” in her history.Presenter:  Michael Weaver, MD, DFASAMProfessorDepartment of Psychiatry and Behavioral SciencesMedical DirectorCenter for Neurobehavioral Research on AddictionMcGovern Medical SchoolUniversity of Texas Health Science Center at HoustonHouston, TexasSung Cheol Kim, MSN, PMHNP-BCAdjunct FacultySchool of NursingVirginia Commonwealth UniversityPsychiatric Nurse PractitionerDepartment of PsychiatryVCU HealthRichmond, VirginiaThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

In this episode,Ameet Nagpal MD, MS, MEd, and Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,discuss the complexities of pain management and the important roles of primary care providers and pain specialists in caring for patients with chronic pain. Listen as they go through a case example to provide insight on the common scenario of inheriting a patient with chronic pain when you do not agree with the previous provider’s treatment plan.Presenters:Ameet Nagpal, MD, MS, MEdIncoming Division ChiefPhysical Medicine & RehabilitationDepartment of Orthopedic Surgery and Physical MedicineMedical University of South CarolinaCharleston, South CarolinaWendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAPOwner and Family Nurse PractitionerWright & Associates Family Healthcare at Amherst and ConcordAmherst, New HampshireThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi

In this episode, Samantha Catanzano, PharmD, BCPP, provides an overview of the life-saving drug naloxone. She discusses its pharmacology, clinical indications, and key role in situations where opioids are prescribed and overdose is possible. Listen as she demonstrates how to discuss naloxone with patients in a nonjudgmental, informative manner.  Presenters:  Samantha Catanzano, PharmD, BCPPClinical Assistant ProfessorDivision of Pharmacy PracticeThe University of Texas at Austin College of PharmacyBoard-Certified Psychiatric PharmacistIntegrated Behavioral Health DepartmentAustin, TexasThis activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please seehttps://bit.ly/3mgrfb9for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.Link to full program:https://bit.ly/3mcDHsi